Anaxiom Announces Early Clinical Results for Novel Obesity Device
Anaxiom Corporation has reported successful early clinical results from a study involving a novel, minimally invasive device for obesity treatment, involving 12 patients. The results indicate device safety and effective weight loss, paving the way for further studies in the U.S.
LAGUNA HILLS, Calif.–(BUSINESS WIRE)– #AnaxiomCorporation–Anaxiom Corporation, a clinical-stage medical device company developing a novel, non-surgical treatment for obesity, today announced the successful completion of a 12-patient OUS clinical study. Early results demonstrate device safety and promising weight loss supporting advancement toward a U.S. Early Feasibility Study. Promising Early Clinical Experience The initial cohort of 12 patients has been successfully treated with no device-related serious advers